| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,037 | 0,039 | 21.03. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.03. | THOMSON MEDICAL GROUP LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::CHANGES IN INTERESTS OF DIRECTOR | 1 | SGX Company Announcements | ||
| 09.03. | THOMSON MEDICAL GROUP LIMITED: EMPLOYEE STOCK OPTION/SHARE SCHEME::ALLOTMENT AND ISSUE OF SHARES PURSUANT TO THE VESTING OF TIME-BASED AWARDS | 1 | SGX Company Announcements | ||
| 12.02. | THOMSON MEDICAL GROUP LIMITED: GENERAL ANNOUNCEMENT::1H FY2026 RESULTS BRIEFING | - | SGX Company Announcements | ||
| 12.02. | Thomson Medical narrows loss to $9.1m in H1 FY2026 on lower costs, steady performance | 3 | Singapore Business Review | ||
| 11.02. | THOMSON MEDICAL GROUP LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::HALF YEARLY RESULTS | 2 | SGX Company Announcements | ||
| 09.02. | THOMSON MEDICAL GROUP LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT BY TMC LIFE SCIENCES BERHAD - 2QFY2026 RESULTS ANNOUNCEMENT | 1 | SGX Company Announcements | ||
| 12.01. | Tong Kooi Ong named chairman of Thomson Medical Group | 3 | The Edge Markets | ||
| THOMSON MEDICAL Aktie jetzt für 0€ handeln | |||||
| 12.01. | THOMSON MEDICAL GROUP LIMITED: GENERAL ANNOUNCEMENT::RECONSTITUTION OF BOARD AND BOARD COMMITTEES | - | SGX Company Announcements | ||
| 12.01. | THOMSON MEDICAL GROUP LIMITED: GENERAL ANNOUNCEMENT::PRESS RELEASE - APPOINTMENT OF NEW CHAIRMAN OF THE BOARD | - | SGX Company Announcements | ||
| 12.01. | THOMSON MEDICAL GROUP LIMITED: CHANGE - ANNOUNCEMENT OF CESSATION::CHANGE - ANNOUNCEMENT OF CESSATION | - | SGX Company Announcements | ||
| 12.01. | THOMSON MEDICAL GROUP LIMITED: CHANGE - ANNOUNCEMENT OF APPOINTMENT::CHANGE - ANNOUNCEMENT OF APPOINTMENT | - | SGX Company Announcements | ||
| 26.11.25 | THOMSON MEDICAL GROUP LIMITED: GENERAL ANNOUNCEMENT::MINUTES OF AGM HELD ON 31 OCTOBER 2025 | 2 | SGX Company Announcements | ||
| 21.11.25 | THOMSON MEDICAL GROUP LIMITED: GENERAL ANNOUNCEMENT::ANNOUNCEMENT BY TMC LIFE SCIENCES BERHAD - 1QFY2026 RESULTS ANNOUNCEMENT | 1 | SGX Company Announcements | ||
| 31.10.25 | THOMSON MEDICAL GROUP LIMITED: CHANGE - ANNOUNCEMENT OF APPOINTMENT::REDESIGNATION OF INDEPENDENT DIRECTOR TO NON-INDEPENDENT AND NON-EXECUTIVE DIRECTOR | 2 | SGX Company Announcements | ||
| 31.10.25 | THOMSON MEDICAL GROUP LIMITED: REPL::ANNUAL GENERAL MEETING::VOLUNTARY | 2 | SGX Company Announcements | ||
| 29.10.25 | THOMSON MEDICAL GROUP LIMITED: GENERAL ANNOUNCEMENT::RESPONSES TO SHAREHOLDERS QUERIES | 1 | SGX Company Announcements | ||
| 24.10.25 | THOMSON MEDICAL GROUP LIMITED: GENERAL ANNOUNCEMENT::IPT - USE OF MARKET CAPITALISATION AS BASIS FOR COMPUTING MATERIALITY THRESHOLDS | 1 | SGX Company Announcements | ||
| 02.10.25 | THOMSON MEDICAL GROUP LIMITED: ANNUAL REPORTS AND RELATED DOCUMENTS | 3 | SGX Company Announcements | ||
| 02.10.25 | THOMSON MEDICAL GROUP LIMITED: ANNUAL GENERAL MEETING::VOLUNTARY | 2 | SGX Company Announcements |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 36,550 | -1,19 % | BERNSTEIN RESEARCH stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Siemens Healthineers mit einem Kursziel von 52,15 Euro auf "Outperform" belassen. Die europäische Medizintechnikbranche... ► Artikel lesen | |
| FRESENIUS | 43,690 | -1,82 % | EQS-DD: Fresenius SE & Co. KGaA: Sara Hennicken, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
16.03.2026 / 17:10... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,740 | -1,38 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| GERRESHEIMER | 21,600 | +21,76 % | BERNSTEIN RESEARCH stuft GERRESHEIMER AG auf 'Underperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Gerresheimer mit einem Kursziel von 18,90 Euro auf "Underperform" belassen. Die europäische Medizintechnikbranche... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 19,100 | -2,35 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results | KIRKLAND, Wash., March 17, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,400 | -0,93 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2025 Results | SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| OTTOBOCK | 46,420 | -9,78 % | EQS-News: Ottobock SE & Co. KGaA: Ottobock veröffentlicht Geschäftsbericht für 2025 | Vorläufige Zahlen bestätigt | Dividendenvorschlag von 0,97 Euro je Aktie | EQS-News: Ottobock SE & Co. KGaA
/ Schlagwort(e): Jahresbericht
Ottobock veröffentlicht Geschäftsbericht für 2025 | Vorläufige Zahlen bestätigt | Dividendenvorschlag von 0,97... ► Artikel lesen | |
| DRAEGERWERK | 85,40 | -2,06 % | Draegerwerk AG & Co. KGaA: Zollentlastung bereits eingepreist, Aufwärtspotenzial wird kleiner, Kursziel erhöht; auf HALTEN gestuft. | Die Zollerlassungen in den USA bieten einen inkrementellen Unterstützungseffekt für die Draegerwerk, jedoch wird der Nutzen voraussichtlich schrittweise erfolgen. Während bestimmte Zölle aufgehoben... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 23,540 | -0,17 % | BERNSTEIN RESEARCH stuft CARL ZEISS MEDITEC AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 28,50 Euro auf "Market-Perform" belassen. Die europäische Medizintechnikbranche... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 41,210 | -6,36 % | Leerink reiterates Outperform on BrightSpring Health stock after investor day | ||
| LIFEMD | 3,900 | -4,41 % | LifeMD, Inc. - 8-K, Current Report | ||
| UNITEDHEALTH | 240,20 | -0,10 % | UNITEDHEALTH GROUP INC stabil in ruhiger Marktphase | ||
| ECKERT & ZIEGLER | 13,750 | -2,62 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| HEARTFLOW | 26,040 | +0,66 % | Heartflow stock price target raised to $43 by Canaccord on guidance | ||
| CO-DIAGNOSTICS | 2,550 | -3,41 % | Co-Diagnostics expands South Asia distribution territory |